Long-term follow up of opicapone as add-on to levodopa in Parkinson&#39;s patients without motor fluctuations.

Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL

http://www.ncbi.nlm.nih.gov/pubmed/41995421

; Angelo Antonini; Fabrizio Stocchi; Helena C Brigas; Joana Moreira; Joaquim J Ferreira; Joerg Holenz; José-Francisco Rocha; Miguel M Fonseca; Olivier Rascol; Werner Poewe

Apr 19, 2026